KR890014124A - Il-6 분자의 사용방법 - Google Patents

Il-6 분자의 사용방법 Download PDF

Info

Publication number
KR890014124A
KR890014124A KR1019890002617A KR890002617A KR890014124A KR 890014124 A KR890014124 A KR 890014124A KR 1019890002617 A KR1019890002617 A KR 1019890002617A KR 890002617 A KR890002617 A KR 890002617A KR 890014124 A KR890014124 A KR 890014124A
Authority
KR
South Korea
Prior art keywords
molecule
manufacture
molecules
treatment
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019890002617A
Other languages
English (en)
Korean (ko)
Inventor
호노레 엠. 페엔 예안
울리히트레크젤
Original Assignee
예안 크라메르.한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805231A external-priority patent/GB8805231D0/en
Priority claimed from GB888810899A external-priority patent/GB8810899D0/en
Application filed by 예안 크라메르.한스 루돌프 하우스, 산도즈 리미티드 filed Critical 예안 크라메르.한스 루돌프 하우스
Publication of KR890014124A publication Critical patent/KR890014124A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
KR1019890002617A 1988-03-04 1989-03-03 Il-6 분자의 사용방법 Withdrawn KR890014124A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH8805231 1988-03-04
GB888805231A GB8805231D0 (en) 1988-03-04 1988-03-04 Improvements in/relating to organic compounds
GB888810899A GB8810899D0 (en) 1988-05-09 1988-05-09 Improvements in/relating to organic compounds
CH8810899 1988-05-09

Publications (1)

Publication Number Publication Date
KR890014124A true KR890014124A (ko) 1989-10-21

Family

ID=26293587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890002617A Withdrawn KR890014124A (ko) 1988-03-04 1989-03-03 Il-6 분자의 사용방법

Country Status (17)

Country Link
EP (1) EP0331640A3 (enExample)
JP (1) JPH01308234A (enExample)
KR (1) KR890014124A (enExample)
AU (1) AU621592B2 (enExample)
BE (1) BE1003662A4 (enExample)
CA (1) CA1332223C (enExample)
CH (1) CH680070A5 (enExample)
DE (1) DE3906923A1 (enExample)
DK (1) DK102389A (enExample)
FR (1) FR2628323B1 (enExample)
GB (1) GB2216412B (enExample)
HU (1) HUT52962A (enExample)
IT (1) IT1230496B (enExample)
NL (1) NL8900524A (enExample)
PH (1) PH26238A (enExample)
PT (1) PT89893A (enExample)
SE (1) SE8900722L (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03197433A (ja) * 1989-12-26 1991-08-28 Otsuka Pharmaceut Co Ltd Ｉｌ―６産生誘導剤
IT1263022B (it) * 1992-11-06 1996-07-23 Angeletti P Ist Richerche Bio Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
RU2136308C1 (ru) * 1994-11-16 1999-09-10 Жемчугов Владислав Евгеньевич Стимулятор роста костно-мозговых клеток человека
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
JP2001158736A (ja) * 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
FI112031B (fi) * 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
JP5069905B2 (ja) 2003-01-21 2012-11-07 アプテュイト （ウエスト ラファイエット）、エルエルシー 新規な共結晶化
CA2555688C (en) * 2004-02-11 2011-11-08 Warner-Lambert Company Llc Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies
GB0912159D0 (en) * 2009-07-14 2009-08-26 Imp Innovations Ltd Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0257406B2 (en) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
US5271931A (en) * 1988-09-14 1993-12-21 The Scripps Research Institute Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6

Also Published As

Publication number Publication date
GB2216412A (en) 1989-10-11
SE8900722D0 (sv) 1989-03-02
DK102389A (da) 1989-09-05
DK102389D0 (da) 1989-03-02
CH680070A5 (enExample) 1992-06-15
EP0331640A2 (en) 1989-09-06
IT8947695A0 (it) 1989-03-01
FR2628323A1 (fr) 1989-09-15
DE3906923A1 (de) 1989-09-14
IT1230496B (it) 1991-10-24
GB8904646D0 (en) 1989-04-12
AU621592B2 (en) 1992-03-19
JPH01308234A (ja) 1989-12-12
PT89893A (pt) 1989-11-10
PH26238A (en) 1992-04-01
SE8900722L (sv) 1989-09-05
HUT52962A (en) 1990-09-28
BE1003662A4 (fr) 1992-05-19
EP0331640A3 (en) 1991-03-13
AU3094289A (en) 1989-09-07
FR2628323B1 (fr) 1994-09-09
CA1332223C (en) 1994-10-04
GB2216412B (en) 1991-10-02
NL8900524A (nl) 1989-10-02

Similar Documents

Publication Publication Date Title
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE67505T1 (de) Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
ATE17079T1 (de) Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
ATE275419T1 (de) Pharmazeutisches kombinationspräparat aus parathormon und einem inhibitor der knochenresorption
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
KR920004391A (ko) 치환된 카복실산의 코데인 염, 이의 제조방법, 이의 용도 및 약제학적 조성물
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE257704T1 (de) Pharmazeutische zusammensetzungen enthaltend norastemizol.
PT76502A (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
DE69420776D1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
RU98101105A (ru) Новое применение в медицинских целях
ATE88633T1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
KR920700627A (ko) 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도
KR890012942A (ko) 5-치환된 오르니틴 유도체
DE3676640D1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
RU2296556C2 (ru) Средство для лечения воспалительных заболеваний пародонта
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890303

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid